How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Malaysian palm oil stockpiles balloon to record on output surge
Jati Tinggi bags RM15.7mil TNB contracts for cable works
Go Hub Capital bags RM64.79mil KTMB ticketing system contract
West River secures RM17.5mil E-Metro Logistic Park subcontract
Yinson secures four-year FPSO extension worth US$600mil
Citaglobal unit bags RM29mil Thailand waste-to-energy project contract
Ringgit ends higher against Asean currencies, eases against US dollar
Southeast Asian property developers brace for slower cycle
Asteel Group secures RM15.8mil Shah Alam logistics complex job
IJM appoints Johan Idris as its chairman

Others Also Read